MyFinsight
Home
Blog
About
Contact
Download
Download image
Product revenue, net
$167,179K
Gain on divestiture
$52,163K
Interest income and other
income (expenses), net
-$475K
(-112.49%↓ Y/Y)
Income from operations
$161,669K
Total interest and
other, net
-$50,738K
(-4156.54%↓ Y/Y)
Total operating costs
and expenses
$5,510K
(-91.27%↓ Y/Y)
Interest expense
$1,900K
(-61.95%↓ Y/Y)
Income before income
taxes
$212,407K
Investment income in
unconsolidated variable...
-$1,375K
Cost of goods sold
$3,761K
(-28.97%↓ Y/Y)
Selling, general and
administrative
$1,311K
(-92.53%↓ Y/Y)
Research and development
$438K
(-97.98%↓ Y/Y)
Income from
discontinued operations, net...
$213,782K
Net income (loss)
$200,636K
(1274.41%↑ Y/Y)
Loss from continuing
operations
-$13,146K
Loss from continuing
operations before income...
-$13,146K
(26.84%↑ Y/Y)
Drug Product Revenue
$957K
Development And Other
Revenue
$119K
Total interest and
other, net
-$7,735K
(-548.91%↓ Y/Y)
Loss from operations
-$5,411K
(67.75%↑ Y/Y)
Interest income and other
income (expenses), net
$931K
(-75.51%↓ Y/Y)
Total revenue
$1,076K
(-97.68%↓ Y/Y)
Loss on debt
extinguishments
-$6,583K
Interest expense
$2,083K
(-58.29%↓ Y/Y)
Total operating costs
and expenses
$6,487K
(-89.72%↓ Y/Y)
Cost of goods sold
-$58K
(-101.10%↓ Y/Y)
Selling, general and
administrative
$5,295K
(-69.84%↓ Y/Y)
Research and development
$1,209K
(-94.43%↓ Y/Y)
Restructuring charge
$41K
(-99.78%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
FIBROGEN INC (FGEN)
FIBROGEN INC (FGEN)